1.Total vaginectomy for refractory vaginal intraepithelial neoplasia III of the vaginal vault.
Ju Hyun YOUN ; Min Ah LEE ; Woong JU ; Seoung Cheol KIM ; Yun Hwan KIM
Obstetrics & Gynecology Science 2016;59(1):71-74
Vaginal intraepithelial neoplasia III, is a relatively rare disease. Consequently standard treatments for this disease were not established until recently. Although several convenient methods, such as laser ablation, 5-fluorouracil topical injection, and radiation therapy, have been applied for treating these lesions, surgical treatments, including vaginectomy, have not yet been attempted, as they would likely be accompanied by technical difficulties and various complications. Herein, we report a case of refractory vaginal intraepithelial neoplasia III in the vaginal vault that was successfully treated with a total vaginectomy.
Fluorouracil
;
Laser Therapy
;
Rare Diseases
2.Expert recommendations on homogenization management of the diagnosis and treatment of rare diseases in children.
Chinese Journal of Contemporary Pediatrics 2023;25(7):663-671
Rare diseases in children are characterized by low prevalence, complex pathogenesis, variety, and difficulty in the diagnosis and treatment. With the development of medical services, progress has been made in the diagnosis and treatment of rare diseases. However, due to asymmetric allocation of medical resources at different levels, there are still many shortcomings in the establishment and promotion of the homogenized management system of rare disease diagnosis and treatment. In order to further standardize the homogenized management of rare diseases in children, achieve early and accurate diagnosis and treatment, and improve the quality of life of the children, the Rare Disease Diagnosis and Treatment Center of Tianjin Children's Hospital (Tianjin University Children's Hospital) invited relevant experts in the field to develop recommendations for the management model of homogenized diagnosis and treatment of rare diseases in children from the aspects of information construction, hierarchical diagnosis and treatment, personnel training, scientific popularization, and multi-participation. The recommendations provide reference for the regional homogenization of clinical diagnosis and treatment management system for children with rare diseases.
Humans
;
Child
;
Rare Diseases/therapy*
;
Quality of Life
3.Clinical diagnostic techniques for rare genetic diseases in children: current status, advances, and thoughts.
Jin-Yue HUANG ; Bi-Li ZHANG ; Wei LIU
Chinese Journal of Contemporary Pediatrics 2023;25(3):308-314
Rare diseases refer to a group of single diseases with low incidence rates, complex pathogeneses, severe disease conditions, and rapid progression. Most rare diseases have a genetic background and may occur in childhood. Paying attention to the rare genetic diseases in children and performing early diagnosis and treatment can effectively delay the course of disease and improve the quality of life of children. Many rare diseases can be diagnosed with the help of various experimental techniques, but the diagnosis of rare diseases is still not widely understood. This article summarizes the laboratory diagnostic techniques currently used for rare genetic diseases in children, so as to provide clues for the diagnosis and treatment of such diseases and help to enhance the theoretical understanding and precise medical treatment of rare genetic diseases in children.
Child
;
Humans
;
Rare Diseases/therapy*
;
Quality of Life
4.Preface.
Lunxu LIU ; Keneng CHEN ; Shugeng GAO
Chinese Journal of Lung Cancer 2018;21(4):251-251
Education, Medical
;
Humans
;
Neoplasms
;
therapy
;
Rare Diseases
;
therapy
5.Current views on rare diseases research and orphan drugs development.
Jingwen JIANG ; Jing LI ; Wenjun LIU
Chinese Journal of Biotechnology 2011;27(5):724-729
Interest in rare diseases research and orphan drugs development has been increased distinctly in recent years. The number of affected people with rare diseases is considerable around the world and the formulation of national and international incentive policies to accelerate orphan drugs development, aiming at offering facilities and necessary conditions for patient access to treatment, gains favorable results. In particular, more measures should be taken to catalyze further progress due to behindhand level in this field in China. Additionally, therapeutic methods of rare diseases were also discussed.
China
;
Humans
;
Orphan Drug Production
;
Rare Diseases
;
genetics
;
therapy
6.Two Cases of Primary Malignant Mixed Mullerian Tumor of the ovary.
Ji Eun LEE ; Seo Yun TONG ; Seon Kyung LEE ; Seung Bo KIM ; Hui Ju LEE
Korean Journal of Obstetrics and Gynecology 2005;48(8):1988-1994
Malignant mixed mullerian tumor of the ovary are very aggressive tumors that were usually diagnosed at an older age. They are usually at an advanced stage at the time of diagnosis, and survival after diagnosis varies by stage of disease and histological type. Despite aggressive treatment that includes surgery and chemotherapy, women with these tumors have a significantly increased risk of death giving them a very poor prognosis. The poor prognosis associated with this rare disease represents a need to new therapeutic regimens to improve patients' survival. We experienced two cases of primary malignant mixed mullerian tumor of the ovary.
Diagnosis
;
Drug Therapy
;
Female
;
Humans
;
Ovary*
;
Prognosis
;
Rare Diseases
7.Two Cases of Primary Malignant Mixed Mullerian Tumor of the ovary.
Ji Eun LEE ; Seo Yun TONG ; Seon Kyung LEE ; Seung Bo KIM ; Hui Ju LEE
Korean Journal of Obstetrics and Gynecology 2005;48(8):1897-1904
Malignant mixed mullerian tumor of the ovary are very aggressive tumors that were usually diagnosed at an older age. They are usually at an advanced stage at the time of diagnosis, and survival after diagnosis varies by stage of disease and histological type. Despite aggressive treatment that includes surgery and chemotherapy, women with these tumors have a significantly increased risk of death giving them a very poor prognosis. The poor prognosis associated with this rare disease represents a need to new therapeutic regimens to improve patients' survival. We experienced two cases of primary malignant mixed mullerian tumor of the ovary.
Diagnosis
;
Drug Therapy
;
Female
;
Humans
;
Ovary*
;
Prognosis
;
Rare Diseases